![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 4-((4-methylpiperazin-1-yl)methyl)-n-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide
2. Ab 1010
3. Ab-1010
4. Ab1010
5. Kinavet
6. Kinavet Ca-1
7. Masatinib
8. Masican
9. Masitinib
10. Masitinib Mesilate
11. Masitinib Methanesulfonate
12. Masivet
13. Masiviera
1. 1048007-93-7
2. Masitinib (mesylate)
3. Masivet
4. Ab-1010 Mesylate
5. Masitinib Mesilate
6. Ab 1010 Mesylate
7. Kinavet
8. Zk89eg3a18
9. Masican
10. Masiviera
11. 4-((4-methylpiperazin-1-yl)methyl)-n-(4-methyl-3-((4-pyridin-3-yl-1,3-thiazol-2-yl)amino)phenyl)benzamide Methanesulfonate
12. 4-((4-methylpiperazin-1-yl)methyl)-n-(4-methyl-3-((4-pyridin-3-yl-1,3-thiazol-2-yl)amino)phenyl)benzamide Methanesulphonate
13. 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide Methanesulfonate
14. Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-thiazolyl)amino)phenyl)-, Methanesulfonate (1:1)
15. Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-thiazolyl)amino)phenyl)-, Methanesulphonate (1:1)
16. 4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide Mesylate
17. 928671-85-6
18. Methanesulfonic Acid;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
19. Unii-zk89eg3a18
20. Masitinibmesylate
21. Schembl1096348
22. Dtxsid70146747
23. Bcp30695
24. Ex-a3996
25. Masitinib Mesilate [who-dd]
26. Yrb00793
27. Hy-10209a
28. Cs-1593
29. Masitinib Mesylate [green Book]
30. Masitinib Methanesulfonate [mi]
31. Sb14845
32. Ac-30896
33. As-56731
34. Ft-0707180
35. C71194
36. Masitinib Mesylate [ema Epar Veterinary]
37. A927557
38. Q27295645
39. Ab1010 Mesylate;ab-1010 Mesylate;ab 1010 Mesylate
40. Masitinib Mesylate Salt; Masitinib Mesilate;ab 1010 Mesylate Pound>>ab1010 Mesylate Pound>>ab-1010 Mesylate
41. N-(4-methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide Methanesulfonate
42. N-(4-methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide Methanesulfonate;
Molecular Weight | 594.8 g/mol |
---|---|
Molecular Formula | C29H34N6O4S2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 7 |
Exact Mass | 594.20829593 g/mol |
Monoisotopic Mass | 594.20829593 g/mol |
Topological Polar Surface Area | 164 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 788 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of amyotrophic lateral sclerosis.
Treatment of mastocytosis
Treatment of non resectable locally advanced or metastatic pancreatic cancer
Treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST)
Treatment of non-resectable dog mast-cell tumours (grade 2 or 3) with confirmed mutated c-KIT tyrosine-kinase receptor.
Treatment of mastocytosis
Treatment of gastro-intestinal stromal tumours
Treatment of amyotrophic lateral sclerosis
L01XE22
L01XE22
L01XE
L01XE
QL01XE90